Nektar Shares Surge On Phase IIb Rezpeg Atopic Dermatitis Data

Atopic Dermatitis is the most common type of eczema, affecting approximately 30 million people in the United States. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D